Protecting Pharmaceutical Innovation
REPORT OF POLITICAL FINANCIAL SUPPORT 2017 Message from the PAC Chair Lilly works to inform our nation’s public policy debates on healthcare in a variety of ways. But currently there is only one in which you and I have the opportunity to be involved: LillyPAC. The PAC uses our financial support to make political contributions to local, state, and federal candidates who share our mission to innovate and make life better for people around the world.
We believe it is important for eligible Lilly employees to be fully informed about LillyPAC’s mission, how we determine candidates to support, who we support, and by how much. This annual report provides a full accounting of the PAC’s financial performance, who serves on the PAC Governing Board, and a list of the local, state, and federal candidates and political committees supported in 2017.
The year 2017 was a time of transition for Lilly. Without a doubt, this impacts the PAC and makes your continued understanding and involvement even more significant. We hope this report shines a bright light on the PAC and shows you how it advances our ability to make life better, transform and grow, and speed innovation.
The LillyPAC Governing Board and I are grateful for the support of more than 2,500 eligible Lilly employees in 2017 and encourage more to come along with us. We look forward to building a stronger LillyPAC in the year ahead to meet the healthcare uncertainties and policy challenges in the current political environment.
Michael J. Harrington General Counsel Chair, LillyPAC Governing Board
LillyPAC Mission LillyPAC brings us together with a united voice to financially support candidates of both parties who will champion policies that advance a positive environment for pharmaceutical innovation. LillyPAC’s mission is to inform local, state, and federal public policymakers about Lilly, encourage public policies that allow us to innovate, and make life better for our patients.
1 | 2017 LillyPAC By The Numbers—LillyPAC 2017
PARTICIPATION RATE OF ELIGIBLE EMPLOYEES 19% ELIGIBLE 2,558 EMPLOYEES GAVE THEIR FINANCIAL Lilly Bio Medicines 33.05% SUPPORT
Lilly Diabetes 42.65%
Elanco 11.34%
Global $983,668 Services BY 20.72% TOTAL VOLUNTARY
Lilly CONTRIBUTIONS FROM BUSINESS International AREA 20.00% LILLY EMPLOYEES
LRL 9.30%
Manufacturing and Quality 9.18%
Lilly Oncology $1,124,950 35.58%
0 10 20 30 40 50 AMOUNT LILLY PAC DONATED TO LOCAL, STATE & FEDERAL 676 CANDIDATES & COMMITTEES 2017 PAC RECEIPTS
Pfi er 2017 LillyPAC Lilly CONTRIBUTIONS BY PARTY Amgen AbbVie Merck J&J Sanofi enentech AstraZeneca 41% SK Democrats Novo Nordisk Bristol Myers 59% Novartis Republicans Astellas 0 $400,000 $800,000 $1,200,000 $1,600,000 $2,000,000
2 | 2017 LillyPAC Where LillyPAC Invests Your Dollars
LillyPAC donated 100% of its receipts to local, state, and federal candidates...